According to P&S Intelligence, the veterinary pain management market was USD 1.60 billion in 2022, which will increase to USD 2.78 billion, with a 7.10% compound annual growth rate, by 2030.
This is because of the surging incidence of musculoskeletal disorders, like osteoarthritis, in animals, coupled with the increasing acceptance of livestock and companion animals. Furthermore, the developments in the animal healthcare industry have resulted in the growing need for veterinary pain management products.
The drug category, on the basis of product, was the largest contributor to the industry in 2022, with over 88% share. This can be because of the surging acceptance of nonsteroidal anti-inflammatory drugs, or NSAIDs, for analgesic purposes in animals.
North America was the largest contributor to the industry in 2022, with approximately 42% share, and it will remain the largest, advancing significantly, in the coming years. This can be because of the increasing occurrence of different infections, such as those caused by parasites, which is leading to the acceptance of animal antibiotics.
Moreover, the increasing companion animal ownership, rising consciousness regarding animal health, and growing count of veterinary hospitals in this continent are further driving the growth.
APAC will advance at the fastest compound annual growth rate in the years to come. This can be because of the increasing export of animal products. This is adding pressure on individuals involved in animal husbandry to maintain animal health, because of the strict product quality demands for exports.
With the surge in the adoption of pets and rising meat & milk consumption, the veterinary pain management industry will continue to progress in the years to come.
Comments